Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02949843
Title Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Comprehensive Cancer Center of Wake Forest University
Indications

lung non-small cell carcinoma

Therapies

Nivolumab + Pembrolizumab

Age Groups: adult | child | senior
Covered Countries USA

Additional content available in CKB BOOST